-
1
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
C.R. Pound, A.W. Partin, M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
-
(1999)
JAMA
, vol.281
, pp. 1591-1597
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
-
2
-
-
0032550753
-
A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
-
M.W. Kattan, J.A. Eastham, A.M. Stapleton A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 766-771
-
-
Kattan, M.W.1
Eastham, J.A.2
Stapleton, A.M.3
-
3
-
-
0030913315
-
Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
-
A.W. Partin, M.W. Kattan, E.N. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445 1451
-
(1997)
JAMA
, vol.277
, pp. 1445-1451
-
-
Partin, A.W.1
Kattan, M.W.2
Subong, E.N.3
-
4
-
-
0033786710
-
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer
-
M.L. Blute, E.J. Bergstralh, A.W. Partin Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer J Urol 164 2000 1591 1595
-
(2000)
J Urol
, vol.164
, pp. 1591-1595
-
-
Blute, M.L.1
Bergstralh, E.J.2
Partin, A.W.3
-
5
-
-
0042674136
-
Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse
-
S.M. Henshall, D.E. Afar, J. Hiller Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse Cancer Res 63 2003 4196 4203
-
(2003)
Cancer Res
, vol.63
, pp. 4196-4203
-
-
Henshall, S.M.1
Afar, D.E.2
Hiller, J.3
-
6
-
-
0038079912
-
Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: A 5-year follow-up study
-
S. Bettuzzi, M. Scaltriti, A. Caporali Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data a 5-year follow-up study Cancer Res 63 2003 3469 3472
-
(2003)
Cancer Res
, vol.63
, pp. 3469-3472
-
-
Bettuzzi, S.1
Scaltriti, M.2
Caporali, A.3
-
7
-
-
0042191696
-
Allelic losses in localized prostate cancer: Association with prognostic factors
-
G. Fromont, V. Joulin, K. Chantrel-Groussard Allelic losses in localized prostate cancer association with prognostic factors J Urol 170 Pt 1 2003 1394 1397
-
(2003)
J Urol
, vol.170
, Issue.1 PART
, pp. 1394-1397
-
-
Fromont, G.1
Joulin, V.2
Chantrel-Groussard, K.3
-
8
-
-
0142008439
-
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer
-
M.W. Kattan, S.F. Shariat, B. Andrews The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer J Clin Oncol 21 2003 3573 3579
-
(2003)
J Clin Oncol
, vol.21
, pp. 3573-3579
-
-
Kattan, M.W.1
Shariat, S.F.2
Andrews, B.3
-
9
-
-
0028808266
-
Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer
-
A. Latil, O. Cussenot, G. Fournier Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer Clin Cancer Res 1 1995 1385 1389
-
(1995)
Clin Cancer Res
, vol.1
, pp. 1385-1389
-
-
Latil, A.1
Cussenot, O.2
Fournier, G.3
-
10
-
-
0034796683
-
Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer
-
H. Matsuyama, Y. Pan, K. Oba Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer Clin Cancer Res 7 2001 3139 3143
-
(2001)
Clin Cancer Res
, vol.7
, pp. 3139-3143
-
-
Matsuyama, H.1
Pan, Y.2
Oba, K.3
-
11
-
-
0030995091
-
Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: Identification of three independent regions
-
A. Latil, O. Cussenot, G. Fournier Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma identification of three independent regions Cancer Res 57 1997 1058 1062
-
(1997)
Cancer Res
, vol.57
, pp. 1058-1062
-
-
Latil, A.1
Cussenot, O.2
Fournier, G.3
-
12
-
-
0029997010
-
Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
-
M.L. Cher, G.S. Bova, D.H. Moore Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping Cancer Res 56 1996 3091 3102
-
(1996)
Cancer Res
, vol.56
, pp. 3091-3102
-
-
Cher, M.L.1
Bova, G.S.2
Moore, D.H.3
-
13
-
-
0033560009
-
Role of radical prostatectomy in patients with prostate cancer of high Gleason score
-
M.V. Tefilli, E.L. Gheiler, R. Tiguert Role of radical prostatectomy in patients with prostate cancer of high Gleason score Prostate 39 1999 60 66
-
(1999)
Prostate
, vol.39
, pp. 60-66
-
-
Tefilli, M.V.1
Gheiler, E.L.2
Tiguert, R.3
-
14
-
-
0032699925
-
P53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy
-
G.B. Stackhouse, I.A. Sesterhenn, J.J. Bauer p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy J Urol 162 1999 2040 2045
-
(1999)
J Urol
, vol.162
, pp. 2040-2045
-
-
Stackhouse, G.B.1
Sesterhenn, I.A.2
Bauer, J.J.3
-
15
-
-
0029922216
-
Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53
-
H.J. Stricker, J.K. Jay, M.D. Linden Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53 Urology 47 1996 366 369
-
(1996)
Urology
, vol.47
, pp. 366-369
-
-
Stricker, H.J.1
Jay, J.K.2
Linden, M.D.3
-
16
-
-
0029795396
-
Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer
-
J.J. Bauer, I.A. Sesterhenn, F.K. Mostofi Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer J Urol 156 1996 1511 1516
-
(1996)
J Urol
, vol.156
, pp. 1511-1516
-
-
Bauer, J.J.1
Sesterhenn, I.A.2
Mostofi, F.K.3
-
17
-
-
0033762814
-
Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer
-
A.N. Vis, M.A. Noordzij, K. Fitoz Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer J Urol 164 2000 2156 2161
-
(2000)
J Urol
, vol.164
, pp. 2156-2161
-
-
Vis, A.N.1
Noordzij, M.A.2
Fitoz, K.3
-
18
-
-
0034049106
-
Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections
-
A.N. Vis, R. Kranse, A.L. Nigg Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections Am J Clin Pathol 113 2000 369 373
-
(2000)
Am J Clin Pathol
, vol.113
, pp. 369-373
-
-
Vis, A.N.1
Kranse, R.2
Nigg, A.L.3
-
19
-
-
0242608654
-
Use of expression analysis to predict outcome after radical prostatectomy
-
P.G. Febbo, W.R. Sellers Use of expression analysis to predict outcome after radical prostatectomy J Urol 170 Pt 2 2003 S11 S19 discussion S19-20.
-
(2003)
J Urol
, vol.170
, Issue.2 PART
-
-
Febbo, P.G.1
Sellers, W.R.2
-
20
-
-
19044391072
-
Gene expression correlates of clinical prostate cancer behavior
-
D. Singh, P.G. Febbo, K. Ross Gene expression correlates of clinical prostate cancer behavior Cancer Cell 1 2002 203 209
-
(2002)
Cancer Cell
, vol.1
, pp. 203-209
-
-
Singh, D.1
Febbo, P.G.2
Ross, K.3
-
21
-
-
0036074561
-
Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer
-
N. Tsuchiya, J.M. Slezak, M.M. Lieber Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer Genes Chromosomes Cancer 34 2002 363 371
-
(2002)
Genes Chromosomes Cancer
, vol.34
, pp. 363-371
-
-
Tsuchiya, N.1
Slezak, J.M.2
Lieber, M.M.3
-
22
-
-
0033568130
-
Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma
-
K. Sato, J. Qian, J.M. Slezak Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma J Natl Cancer Inst 91 1999 1574 1580
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1574-1580
-
-
Sato, K.1
Qian, J.2
Slezak, J.M.3
-
23
-
-
0031938047
-
Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer
-
R. Jenkins, S. Takahashi, K. DeLacey Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer Genes Chromosomes Cancer 21 1998 131 143
-
(1998)
Genes Chromosomes Cancer
, vol.21
, pp. 131-143
-
-
Jenkins, R.1
Takahashi, S.2
Delacey, K.3
-
24
-
-
0029116273
-
Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression
-
S. Takahashi, A.L. Shan, S.R. Ritland Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression Cancer Res 55 1995 4114 4119
-
(1995)
Cancer Res
, vol.55
, pp. 4114-4119
-
-
Takahashi, S.1
Shan, A.L.2
Ritland, S.R.3
-
25
-
-
0035065492
-
Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31
-
J.C. Zenklusen, C.J. Conti, E.D. Green Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31 Nat Genet 27 2001 392 398
-
(2001)
Nat Genet
, vol.27
, pp. 392-398
-
-
Zenklusen, J.C.1
Conti, C.J.2
Green, E.D.3
-
26
-
-
0042329653
-
Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion
-
A. Latil, L. Chene, P. Mangin Extensive analysis of the 13q14 region in human prostate tumors DNA analysis and quantitative expression of genes lying in the interval of deletion Prostate 57 2003 39 50
-
(2003)
Prostate
, vol.57
, pp. 39-50
-
-
Latil, A.1
Chene, L.2
Mangin, P.3
-
27
-
-
0035155439
-
Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer
-
J.T. Dong, J.C. Boyd, H.F. Frierson Jr Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer Prostate 49 2001 166 171
-
(2001)
Prostate
, vol.49
, pp. 166-171
-
-
Dong, J.T.1
Boyd, J.C.2
Frierson Jr., H.F.3
-
28
-
-
0345374576
-
Genome-wide scan of brothers: Replication and fine mapping of prostate cancer susceptibility and aggressiveness loci
-
J.S. Witte, B.K. Suarez, B. Thiel Genome-wide scan of brothers replication and fine mapping of prostate cancer susceptibility and aggressiveness loci Prostate 57 2003 298 308
-
(2003)
Prostate
, vol.57
, pp. 298-308
-
-
Witte, J.S.1
Suarez, B.K.2
Thiel, B.3
-
30
-
-
0033921023
-
Loss of heterozygosity at 12P12-13 in primary and metastatic prostate adenocarcinoma
-
A.S. Kibel, D.A. Faith, G.S. Bova Loss of heterozygosity at 12P12-13 in primary and metastatic prostate adenocarcinoma J Urol 164 2000 192 196
-
(2000)
J Urol
, vol.164
, pp. 192-196
-
-
Kibel, A.S.1
Faith, D.A.2
Bova, G.S.3
|